COST UTILITY ANALYSIS OF HPV VACCINATION WITH BIVALENT AS04 ADJUVANT VACCINE IN SLOVAKIA AND IMPACT OF VACCINE PROTECTION DURATION ON COST-EFFECTIVENESS ENDPOINTS

被引：0
|
作者：
Bielik, J. [1 ]
Foltan, V [2 ]
Psenkova, M. [3 ]
Hroncova, D. [4 ]
Marusakova, E. [5 ]
Sadovsky, O. [6 ]
机构：
[1] Fac Hlth, Trencin, Slovakia
[2] Comenius Univ, Bratislava, Slovakia
[3] Spol S Ro, Pharm In, Bratislava, Slovakia
[4] GSK, Noncommercial Educ Ctr, Bratislava, Slovakia
[5] GlaxoSmithKline Slovakia, Bratislava, Slovakia
[6] Natl Oncol Inst, Bratislava, Slovakia
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)73257-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A541 / A542
页数：2
相关论文
共 50 条
  • [11] Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
    Francesco Saverio Mennini
    Paolo Bonanni
    Florence Bianic
    Chiara de Waure
    Gianluca Baio
    Giacomo Plazzotta
    Mathieu Uhart
    Alessandro Rinaldi
    Nathalie Largeron
    Cost Effectiveness and Resource Allocation, 15
  • [12] Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
    Michaeli, Daniel Tobias
    Stoycheva, Sophia
    Marcus, Simon Mashudu
    Zhang, Wenjia
    Michaeli, Julia Caroline
    Michaeli, Thomas
    CLINICAL DRUG INVESTIGATION, 2022, 42 (04) : 333 - 343
  • [13] The impact of indirect (Herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine
    Isaacman, Daniel J.
    Strutton, David R.
    Kalpas, Edward A.
    Horowicz-Mehler, Nathalie
    Stern, Lee S.
    Casciano, Roman
    Ciuryla, Vincent
    CLINICAL THERAPEUTICS, 2008, 30 (02) : 341 - 357
  • [14] Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
    Daniel Tobias Michaeli
    Sophia Stoycheva
    Simon Mashudu Marcus
    Wenjia Zhang
    Julia Caroline Michaeli
    Thomas Michaeli
    Clinical Drug Investigation, 2022, 42 : 333 - 343
  • [15] Varicella, vaccine, cost-effectiveness analyses, and vaccination policy
    Davis, MM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (07): : 845 - 846
  • [16] Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
    Schobert, Deniz
    Remy, Vanessa
    Schoeffski, Oliver
    HEALTH ECONOMICS REVIEW, 2012, 2
  • [17] COST-EFFECTIVENESS ANALYSIS OF HPV VACCINATION IN SLOVENIA
    Obradovic, M.
    Mrhar, A.
    Kos, M.
    VALUE IN HEALTH, 2009, 12 (07) : A272 - A272
  • [18] Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
    Deniz Schobert
    Vanessa Remy
    Oliver Schoeffski
    Health Economics Review, 2 (1)
  • [19] Cost-effectiveness of mass vaccination with a rotavirus vaccine in the Netherlands
    Al, M. J.
    Goossens, L.
    Hovels, A. M.
    Michielsen, C. P.
    Standaert, B. A.
    VALUE IN HEALTH, 2006, 9 (06) : A304 - A304
  • [20] Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
    De La Fuente, Jesus
    Hernandez Aguado, Juan Jose
    San Martin, Maria
    Ramirez Boix, Paula
    Cedillo Gomez, Sergio
    Lopez, Noelia
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (7-8) : 1949 - 1961
12345